Does gender-specific risk of cardiovascular events in type 2 diabetic patients depend on the type of treatment? The question remains open

Pharmacol Res. 2017 May:119:476. doi: 10.1016/j.phrs.2017.03.006. Epub 2017 Mar 12.

Authors

Ilaria Campesi¹, Flavia Franconi², Giuseppe Seghieri³, Marco Meloni⁴

Affiliations

¹ Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
² Department of Biomedical Sciences, University of Sassari, Sassari, Italy; Dipartimento Politiche della Persona Regione Basilicata, Basilicata, Italy.
³ Centro Studi Salute di Genere, AUSL3, Pistoia, Italy.
⁴ BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

PMID: 28300616
DOI: 10.1016/j.phrs.2017.03.006

No abstract available

Publication types

Letter

MeSH terms

Cardiovascular Diseases / etiology*
Cardiovascular Diseases / physiopathology*
Diabetes Mellitus, Type 2 / physiopathology*
Humans
Risk
Risk Factors
Sex Characteristics